Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Avalyn Pharma Inc. (AVLN)

NASDAQ

$28.85

$-1.42

(-4.76%)

Avalyn Pharma Inc. (AVLN) Live Price Chart

Page last updated: 2026-05-04 19:34:38

Key Market Data

Market Cap	$1.21B
Open	$30.14
High	$33.22
Low	$26.00
Previous Close	$29.84
Price Change	$-1.42
Percentage Change	-4.76%
Volume	264K

Avalyn Pharma Inc. (AVLN) Stock Price Today

Avalyn Pharma Inc. (AVLN) is currently trading at $28.85 as of 2026-05-04 19:34:38, reflecting a -4.76% move ($-1.42) from the previous close.

In the short term, the stock has returned -2.18% over the past four weeks. Over the last 12 months, Avalyn Pharma Inc. has recorded a -2.18% price change, indicating a Weak performance relative to the broader market.

Avalyn Pharma Inc. (AVLN) 7-Day Stock Price Changes

Over the past seven days, Avalyn Pharma Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $26.00 to the latest recorded price of $28.85, reflecting an intraday change of -4.76%. Daily movements highlight shifts in trading volume (263,617), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, AVLN has delivered a -2.18% return over the past month and a -2.18% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Avalyn Pharma Inc. (AVLN)

You can buy and trade AVLN on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for AVLN and Execute Your Trade

Open the trading page, enter AVLN in the search bar, select the amount of AVLN you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Avalyn Pharma Inc. (AVLN)?

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Avalyn Pharma Inc. Information

Industry	--
Employees	--
Sector	--
Company Website	https://www.avalynpharma.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Avalyn Pharma Inc.?

The latest trading price for Avalyn Pharma Inc. (Common Stock) is $ 28.85, compared with a previous closing price of $ 29.84. That means the stock has moved -4.76% so far today. Intraday price updates and recent trading activity for AVLN can be tracked on the live chart and quote section on this page.

2.Is Avalyn Pharma Inc. stock going up or down?

Looking at recent performances, AVLN has returned -2.18% over the past month, -2.18% over the last six months and -2.18% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for Avalyn Pharma Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does AVLN currently sit relative to its 52-week high and low?

In the most recent 52-week period, Avalyn Pharma Inc. has traded between a low of $ 26.00 and a high of $ 33.22. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether AVLN is currently nearer the top or the bottom of its one-year trading band.

4.How is Avalyn Pharma Inc. classified by sector and industry?

Avalyn Pharma Inc. is classified in the -- sector. In practice, this means Avalyn Pharma Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing AVLN’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Avalyn Pharma Inc.’s performance.

5.Where is Avalyn Pharma Inc. listed and how large is it by market value?

Avalyn Pharma Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 1.21B, the company is classified as a Small-cap stock. Market cap gives a quick sense of Avalyn Pharma Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does AVLN's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Avalyn Pharma Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Avalyn Pharma Inc.'s financial performance over time?

To follow Avalyn Pharma Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how AVLN is performing and how the market is responding.

8.When is Avalyn Pharma Inc. expected to report earnings?

Avalyn Pharma Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for AVLN, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Avalyn Pharma Inc.'s earnings reports?

Avalyn Pharma Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether AVLN is meeting, beating or missing expectations.

10.How can I stay informed about Avalyn Pharma Inc.'s results and guidance?

You can stay up to date on Avalyn Pharma Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for AVLN on this page helps you see how new information is being reflected in the stock.

11.Does Avalyn Pharma Inc. pay a regular cash dividend to its shareholders?

Avalyn Pharma Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor AVLN's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for AVLN?

Based on the latest earnings data, AVLN has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Avalyn Pharma Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Avalyn Pharma Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Avalyn Pharma Inc.?

Avalyn Pharma Inc. is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is AVLN valued in terms of P/E ratio and EPS?

Avalyn Pharma Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Avalyn Pharma Inc.'s earnings. Comparing AVLN's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

AVLN-to-USD Calculator

Amount

AVLN

USD

1 AVLN = 28.847 USD